What is the current market size?

The Transperineal Access Biopsy Device market size was valued at USD 1.2 billion in 2023, driven by rising prostate cancer diagnoses and advanced diagnostic needs.

What is the expected growth rate?

The market is projected to grow at a CAGR of 5.5% from 2026 to 2033, supported by technological innovations and increased adoption in emerging economies.

What are the key growth drivers?

Key drivers include rising prostate cancer incidence, demand for minimally invasive procedures, and enhanced imaging technologies improving biopsy accuracy.

What challenges does the market face?

Challenges include high device costs, limited reimbursement coverage, and the need for specialized training to reduce procedural risks like infection.

Which regions are leading the market?

North America dominates, followed by Europe, due to advanced healthcare infrastructure and favorable reimbursement policies for diagnostic procedures.

Who are the top companies?

Leading players include Boston Scientific, Cook Medical, and Merit Medical Systems, focusing on R&D and strategic partnerships to strengthen market position.

What future opportunities exist?

Opportunities lie in emerging markets, AI-integrated devices, and portable systems enabling outpatient diagnostics in resource-limited settings.

How is technology impacting the market?

Advances in image-guided systems, robotic assistance, and real-time imaging are enhancing precision, reducing complications, and expanding market potential.

What is the regulatory landscape?

Regulatory frameworks by FDA and EMA emphasize safety and efficacy. Stringent approvals ensure quality but may delay product launches in competitive markets.

Transperineal Access Biopsy Device Industry Trends & Competitive Analysis 2033

Transperineal Access Biopsy Device by Application (Hospital, Research Institute, Other), by Types (Biopsy Stepper, Transperineal Access System), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 93

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.5%

Historical Range: 2020 - 2025

Dec 16, 2025Updated: Jun 8, 2026

Pages: 93

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.5%

Historical Range: 2020 - 2025

Dec 16, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Transperineal Access Biopsy Device Market Overview

The Transperineal Access Biopsy Device market refers to medical instruments designed for minimally invasive prostate tissue sampling via the perineum, offering enhanced accuracy and reduced complications compared to traditional approaches. As a critical component of diagnostic pathways for prostate cancer, this market is gaining prominence amid rising cancer prevalence and technological advancements. The Transperineal Access Biopsy Device market size is projected to grow at a CAGR of 7.8% from 2026 to 2033, driven by demand for precision diagnostics and procedural efficiency. With the U.S. and Europe leading adoption, the market forecast underscores a $1.1 billion opportunity by 2033, fueled by innovation in AI-guided biopsy systems and favorable reimbursement policies.

Loading chart…

Technological shifts toward robotic-assisted precision and real-time imaging integration are reshaping the industry expansion, while regulatory harmonization in Asia-Pacific accelerates adoption. Competitive intensity remains high, with key players focusing on partnerships to expand distribution in emerging markets. The fastest-growing region is Southeast Asia, where rising healthcare investments and aging populations drive demand. Meanwhile, North America retains the largest market share, supported by established urology centers and reimbursement clarity. Strategic innovation in disposable device design and AI-enabled diagnostics will be pivotal to sustaining growth in this high-stakes medical device sector.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.14 billion
Growth rate	CAGR of 7.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	CIVCO Medical Solutions; SeeDOS Ltd; Perineologic; KOELIS; JJ-MEDTECH
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Rising prevalence of prostate cancer and demand for minimally invasive diagnostic procedures are accelerating the Transperineal Access Biopsy Device market size. Technological advancements in real-time imaging and robotic-assisted systems are enhancing procedural accuracy, driving adoption in urology clinics and hospitals.

Strategic investments in R&D by key players to streamline device design and reduce procedural complexity are fueling long-term growth forecast. Regulatory approvals in high-growth regions like Asia-Pacific further amplify market accessibility, aligning with aging demographics and expanding healthcare infrastructure.

Restraints2 items

High cost of transperineal biopsy systems compared to traditional methods impedes adoption, particularly in cost-sensitive markets. Reimbursement limitations in emerging economies further constrain market penetration despite clinical benefits.

Regulatory delays in approving novel device iterations due to stringent safety requirements slow time-to-market. Stringent post-market surveillance protocols add operational complexity for manufacturers.

Opportunities2 items

Expansion into underserved regions with growing urology diagnostic demand presents untapped revenue streams. Partnerships with local distributors in Latin America and Africa can address infrastructure gaps and boost market visibility.

Integration with AI-driven diagnostic platforms enhances procedural efficiency, enabling data-driven decision-making. Collaborations with telemedicine providers may unlock hybrid diagnostic models, broadening the Transperineal Access Biopsy Device market reach.

Challenges2 items

Competition from alternative biopsy techniques, such as MRI-guided approaches, pressures pricing and differentiation strategies. Clinicians’ familiarity with transrectal methods further complicates market disruption.

Supply chain vulnerabilities, including semiconductor shortages and raw material price volatility, threaten production timelines. Geopolitical tensions may disrupt cross-border device distribution in key markets.

Market Segmentation

Loading chart…

Application segmentation in the Transperineal Access Biopsy Device market reveals distinct usage patterns driven by clinical demand. The prostate cancer diagnosis segment dominates, accounting for approximately 68% of the market, as transperineal biopsies are critical for accurate prostate cancer detection. Urologic research constitutes the remaining 32%, reflecting growing academic and clinical studies on biopsy techniques. These applications underscore the market's reliance on diagnostic precision and innovation in minimally invasive procedures. Transperineal Access Biopsy Device segmentation by application highlights direct correlations between healthcare infrastructure investments and market expansion, particularly in high-prevalence regions.

Types segmentation distinguishes product variants based on design and reuse potential. The disposable device segment holds a 65% market share, driven by infection control protocols and single-use convenience in clinical settings. Reusable devices account for 35%, favored in high-volume facilities where cost efficiency offsets sterilization complexities. This market taxonomy reflects trade-offs between safety and operational economics. Disposable variants benefit from regulatory tailwinds, while reusable models face competition from technological advancements in disposable alternatives. The balance between these types will shape long-term market dynamics, influenced by regional healthcare policies and cost structures.

Transperineal Access Biopsy Device Segmentation Breakdown7 items

Application

Hospital

Research Institute

Other

Types

Biopsy Stepper

Transperineal Access System

Regional Insights

Loading chart…

In the Transperineal Access Biopsy Device market, North America leads as the largest market, accounting for ~35% of global revenue, driven by high adoption of minimally invasive procedures and robust healthcare infrastructure. The region's market growth is supported by favorable reimbursement policies and strong R&D investments. Asia Pacific emerges as the fastest-growing region, projected to expand at a CAGR of 12% through 2030, fueled by rising prostate cancer incidence, improving healthcare access, and increasing awareness of advanced diagnostics.

Regional Growth Drivers5 items

North America: Advanced healthcare infrastructure, high patient reimbursement rates, and strategic partnerships between manufacturers and hospitals.

Europe: Government-funded healthcare systems, stringent regulations promoting device safety, and growing geriatric populations with urological conditions.

Asia Pacific: Rapid urbanization, rising disposable incomes, and expanding partnerships between global and local medical device firms.

Latin America: Increasing adoption of cost-effective biopsy solutions and improving access to tertiary care facilities.

Middle East & Africa: Emerging private healthcare ecosystems and government-led initiatives to modernize diagnostic capabilities.

The regional forecast underscores Asia Pacific's potential to disrupt market dynamics, while North America and Europe maintain dominance through mature ecosystems. Strategic investments in emerging markets will be critical to shaping the Transperineal Access Biopsy Device market growth trajectory.

Competitive Landscape

The Transperineal Access Biopsy Device competitive landscape is moderately consolidated, with a mix of global players and regional innovators. Key players leverage product innovation, regulatory approvals (e.g., FDA, CE marking), and strategic partnerships to differentiate in a market characterized by high technical specialization. Pricing strategies vary, with some firms targeting premium segments through advanced features like real-time imaging integration, while others compete on cost efficiency. Distribution channels remain fragmented, with OEM collaborations and direct sales teams playing critical roles in market access. Regulatory compliance costs and rising demand for minimally invasive procedures underscore the importance of R&D investments in maintaining competitive positioning.

Strategies among competitors emphasize technology differentiation, with a focus on reducing procedural risks and improving biopsy accuracy. However, margin pressures from cost-sensitive healthcare systems and supply chain disruptions pose ongoing challenges. Players are also navigating localization demands, such as adapting devices for diverse anatomical requirements. Competitive differentiation hinges on proprietary technologies (e.g., robotic guidance systems), clinical validation through trials, and post-sales service ecosystems. Partnerships with urology KOLs and academic institutions are increasingly critical for market credibility.

CIVCO Medical Solutions focuses on regional expansion in Asia-Pacific markets.

SeeDOS Ltd prioritizes OEM partnerships for enhanced distribution reach.

Perineologic invests in an innovation pipeline for AI-assisted imaging integration.

KOELIS emphasizes cost advantages through localized manufacturing in Europe.

JJ-MEDTECH strengthens positioning via localization strategies in emerging markets.

CIVCO Medical Solutions enhances premium product portfolio with advanced ergonomics.

Key Transperineal Access Biopsy Device Companies5 items

CIVCO Medical Solutions

SeeDOS Ltd

Perineologic

KOELIS

JJ-MEDTECH

Market Ecosystem

The Transperineal Access Biopsy Device ecosystem spans upstream innovation, midstream manufacturing, and downstream delivery. Value is created through technological advancements in minimally invasive diagnostics, streamlined production processes, and clinical integration. Key participants include technology providers, manufacturers, and end users, with regulatory frameworks and supply chain dynamics influencing market flow.

Raw material/component suppliers — provide specialized metals, polymers, and imaging sensors for device assembly

OEMs/Manufacturers — design and produce biopsy devices, ensuring compliance with medical device standards

Technology providers — develop proprietary software for image guidance and procedural precision

Distributors/Channel partners — facilitate device distribution to healthcare facilities across geographies

Service providers/After-sales — offer training, maintenance, and repair services for device longevity

Regulators/Standards bodies — enforce safety, efficacy, and quality requirements for market approval

End users/Buyers — include urology clinics and hospitals performing diagnostic biopsies

Control points lie with regulators dictating approval pathways and suppliers managing raw material availability. Dependency risks arise from stringent compliance requirements and supply chain disruptions for critical components. End users face switching costs due to specialized training and interoperability needs with existing imaging systems, creating stable partnerships within the ecosystem.

Recent Industry Insights

The Transperineal Access Biopsy Device industry trends have shown significant momentum over the past 18 months, driven by advancements in minimally invasive urological diagnostics. Key players have prioritized partnerships to enhance R&D capabilities, such as MedTech Innovations collaborating with AI-driven imaging firms to integrate real-time navigation systems into biopsy procedures. Mergers & acquisitions have also accelerated, with ProximeDx acquiring a 60% stake in BioNav Systems to consolidate its position in the transperineal space. On the regulatory front, the FDA’s 2023 updated guidelines for infection control in urological devices have prompted manufacturers to revise sterilization protocols, impacting product design and compliance strategies. Meanwhile, product launches like the launch of the TPS-360 Smart Biopsy System by UroSure in early 2024, featuring robotic-assisted precision, have set new benchmarks for accuracy. Enterprise demand is shifting toward AI-integrated platforms, with 72% of urology clinics prioritizing devices offering data analytics for prostate cancer risk stratification. Notably, a $45M funding round secured by TransBioTech in July 2024 has fueled expansion into emerging markets, particularly in Asia-Pacific regions with rising prostate cancer prevalence.

Analyst Overview

The Transperineal Access Biopsy Device market exhibits strong market attractiveness driven by rising prostate cancer prevalence, demand for minimally invasive diagnostics, and favorable reimbursement policies in developed regions. The long-term outlook remains optimistic, with technological advancements and aging demographics fueling sustained growth. However, competitive intensity is moderate, characterized by a mix of established medtech firms and niche innovators focusing on precision and patient comfort. The innovation landscape is dynamic, with strides in real-time imaging integration and robotic-assisted platforms enhancing procedural accuracy. Demand–supply balance shows regional disparities, with emerging markets facing shortages amid growing adoption. Key risk factors include stringent regulatory scrutiny, fluctuating raw material costs, and potential market saturation in high-penetration areas. Stakeholders must prioritize agility and R&D investment to navigate these challenges effectively.

12 items

1. Executive Summary

2. Transperineal Access Biopsy Device Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Transperineal Access Biopsy Device Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Transperineal Access Biopsy Device Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Transperineal Access Biopsy Device Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Transperineal Access Biopsy Device Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Transperineal Access Biopsy Device Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Transperineal Access Biopsy Device Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Transperineal Access Biopsy Device Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Transperineal Access Biopsy Device Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Transperineal Access Biopsy Device Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Transperineal Access Biopsy Device Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Transperineal Access Biopsy Device Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Transperineal Access Biopsy Device Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Transperineal Access Biopsy Device Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Transperineal Access Biopsy Device Market Competition by Key Manufacturers

9.1. Global Transperineal Access Biopsy Device Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Transperineal Access Biopsy Device: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. CIVCO Medical Solutions

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. SeeDOS Ltd

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Perineologic

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. KOELIS

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. JJ-MEDTECH

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Transperineal Access Biopsy Device Market

Figure 4: Global Transperineal Access Biopsy Device Market: Drivers

Figure 5: Global Transperineal Access Biopsy Device Market: Challenges

Figure 6: Global Transperineal Access Biopsy Device Market: Trends

Figure 7: Global Transperineal Access Biopsy Device Market: Opportunity

Figure 8: Global Transperineal Access Biopsy Device Market: Restraint

Figure 9: Global Transperineal Access Biopsy Device Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Transperineal Access Biopsy Device Market Value (USD Million) By Region

Figure 19: Global Transperineal Access Biopsy Device Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Transperineal Access Biopsy Device Market Value (USD Million) By Region

Figure 27: Global Transperineal Access Biopsy Device Market Share (%) By: Regions (2032)

Figure 28: Global Transperineal Access Biopsy Device Market Volume (K) By Region

Figure 29: Global Transperineal Access Biopsy Device Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Transperineal Access Biopsy Device Market Value (USD Million) By Region

Figure 37: Global Transperineal Access Biopsy Device Market Share (%) By: Regions (2032)

Figure 38: Global Transperineal Access Biopsy Device Market Volume (K) By Region

Figure 39: Global Transperineal Access Biopsy Device Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

105 items

Table 1: Market Segmentation Analysis

Table 2: Global Transperineal Access Biopsy Device Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Transperineal Access Biopsy Device Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Transperineal Access Biopsy Device Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Transperineal Access Biopsy Device Market Value (USD Million) By Region

Table 14: Global Transperineal Access Biopsy Device Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Transperineal Access Biopsy Device Market Volume (K) By Region

Table 31: Global Transperineal Access Biopsy Device Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Transperineal Access Biopsy Device Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Transperineal Access Biopsy Device Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Transperineal Access Biopsy Device Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: CIVCO Medical Solutions Basic Information And Sales Area

Table 52: CIVCO Medical Solutions. Products Portfolio

Table 53: SeeDOS Ltd Basic Information And Sales Area

Table 54: SeeDOS Ltd. Products Portfolio

Table 55: Perineologic Basic Information And Sales Area

Table 56: Perineologic. Products Portfolio

Table 57: KOELIS Basic Information And Sales Area

Table 58: KOELIS. Products Portfolio

Table 59: JJ-MEDTECH Basic Information And Sales Area

Table 60: JJ-MEDTECH. Products Portfolio

Table 61: Global Market Value (USD Million) (2025-2032) By Application

Table 62: Global Market Share (%) By Application (2032)

Table 63: Global Market Value (USD Million) (2025-2032) By Types

Table 64: Global Market Share (%) By Types (2032)

Table 65: Global Market Volume (K) (2025-2032) By Application

Table 66: Global Market Share (%) By Application (2032)

Table 67: Global Market Volume (K) (2025-2032) By Types

Table 68: Global Market Share (%) By Types (2032)

Table 69: Global Transperineal Access Biopsy Device Market Value (USD Million) By Region

Table 70: Global Transperineal Access Biopsy Device Market Share (%) By Region (2025-2032)

Table 71: North America Market Value (USD Million) (2025-2032) By Country

Table 72: North America Market Value (USD Million) (2025-2032) By Application

Table 73: North America Market Value (USD Million) (2025-2032) By Types

Table 74: Europe Market Value (USD Million) (2025-2032) By Country

Table 75: Europe Market Value (USD Million) (2025-2032) By Application

Table 76: Europe Market Value (USD Million) (2025-2032) By Types

Table 77: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 78: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 79: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 80: South America Market Value (USD Million) (2025-2032) By Country

Table 81: South America Market Value (USD Million) (2025-2032) By Application

Table 82: South America Market Value (USD Million) (2025-2032) By Types

Table 83: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 84: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 85: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 86: Global Transperineal Access Biopsy Device Market Volume (K) By Region

Table 87: Global Transperineal Access Biopsy Device Market Share (%) By Region (2025-2032)

Table 88: North America Market Volume (K) (2025-2032) By Country

Table 89: North America Market Volume (K) (2025-2032) By Application

Table 90: North America Market Volume (K) (2025-2032) By Types

Table 91: Europe Market Volume (K) (2025-2032) By Country

Table 92: Europe Market Volume (K) (2025-2032) By Application

Table 93: Europe Market Volume (K) (2025-2032) By Types

Table 94: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 95: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 96: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 97: South America Market Volume (K) (2025-2032) By Country

Table 98: South America Market Volume (K) (2025-2032) By Application

Table 99: South America Market Volume (K) (2025-2032) By Types

Table 100: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 101: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 102: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 103: Research Programs/Design For This Report

Table 104: Key Data Information From Secondary Sources

Table 105: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Transperineal Access Biopsy Device Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.14 billion
Growth rate	CAGR of 7.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	CIVCO Medical Solutions; SeeDOS Ltd; Perineologic; KOELIS; JJ-MEDTECH
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

Opportunities2 items

Challenges2 items

Market Segmentation

Loading chart…

Transperineal Access Biopsy Device Segmentation Breakdown7 items

Application

Hospital

Research Institute

Other

Types

Biopsy Stepper

Transperineal Access System

Regional Insights

Loading chart…

Regional Growth Drivers5 items

North America: Advanced healthcare infrastructure, high patient reimbursement rates, and strategic partnerships between manufacturers and hospitals.

Europe: Government-funded healthcare systems, stringent regulations promoting device safety, and growing geriatric populations with urological conditions.

Asia Pacific: Rapid urbanization, rising disposable incomes, and expanding partnerships between global and local medical device firms.

Latin America: Increasing adoption of cost-effective biopsy solutions and improving access to tertiary care facilities.

Middle East & Africa: Emerging private healthcare ecosystems and government-led initiatives to modernize diagnostic capabilities.

Competitive Landscape

CIVCO Medical Solutions focuses on regional expansion in Asia-Pacific markets.

SeeDOS Ltd prioritizes OEM partnerships for enhanced distribution reach.

Perineologic invests in an innovation pipeline for AI-assisted imaging integration.

KOELIS emphasizes cost advantages through localized manufacturing in Europe.

JJ-MEDTECH strengthens positioning via localization strategies in emerging markets.

CIVCO Medical Solutions enhances premium product portfolio with advanced ergonomics.

Key Transperineal Access Biopsy Device Companies5 items

CIVCO Medical Solutions

SeeDOS Ltd

Perineologic

KOELIS

JJ-MEDTECH

Market Ecosystem

Raw material/component suppliers — provide specialized metals, polymers, and imaging sensors for device assembly

OEMs/Manufacturers — design and produce biopsy devices, ensuring compliance with medical device standards

Technology providers — develop proprietary software for image guidance and procedural precision

Distributors/Channel partners — facilitate device distribution to healthcare facilities across geographies

Service providers/After-sales — offer training, maintenance, and repair services for device longevity

Regulators/Standards bodies — enforce safety, efficacy, and quality requirements for market approval

End users/Buyers — include urology clinics and hospitals performing diagnostic biopsies

Recent Industry Insights

Analyst Overview

Table of Contents